HA
HC Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,507
| Closed | -$210K | – | 92 |
|
|
2023
Q4 | $210K | Buy |
+3,507
| New | +$210K | 0.12% | 85 |
|
|
2023
Q3 | – | Sell |
-3,128
| Closed | -$285K | – | 85 |
|
|
2023
Q2 | $285K | Sell |
3,128
-250
| -7% | -$22.8K | 0.17% | 67 |
|
|
2023
Q1 | $223K | Sell |
3,378
-2,347
| -41% | -$155K | 0.14% | 73 |
|
|
2022
Q4 | $296K | Sell |
5,725
-35,640
| -86% | -$1.84M | 0.2% | 65 |
|
|
2022
Q3 | $2.83M | Buy |
41,365
+34,186
| +476% | +$2.33M | 1.95% | 15 |
|
|
2022
Q2 | $325K | Buy |
7,179
+300
| +4% | +$13.6K | 0.23% | 57 |
|
|
2022
Q1 | $350K | Sell |
6,879
-5,181
| -43% | -$264K | 0.22% | 57 |
|
|
2021
Q4 | $570K | Buy |
+12,060
| New | +$570K | 0.35% | 43 |
|
|
2021
Q3 | – | Sell |
-3,310
| Closed | -$209K | – | 82 |
|
|
2021
Q2 | $209K | Sell |
3,310
-2,213
| -40% | -$140K | 0.13% | 76 |
|
|
2021
Q1 | $237K | Sell |
5,523
-195
| -3% | -$8.37K | 0.15% | 67 |
|
|
2020
Q4 | $327K | Buy |
+5,718
| New | +$327K | 0.22% | 57 |
|